<!DOCTYPE HTML>

<html>
<head>
<title> Summary + Date</title>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1, user-scalable=no" name="viewport"/>
<link href="assets/css/sum_pg.css" rel="stylesheet"/>
</head>
<!-- Google tag (gtag.js) -->
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-K51JJ2RCJJ"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-K51JJ2RCJJ');
</script>
<body class="is-preload">
<!-- Header -->
<header id="header">
<h1 style="margin-top: 0 !important; padding-top: 0 !important;">MAD MONEY Summaries</h1>
<!-- <p>AI-generated summaries for the show Mad Money hosted by Jim Cramer. -->
<h2 id="show_date_append_here"> Show Date: February 04, 2025</h2>
<p id="append_audio_link_here"> <a href="https://www.youtube.com/watch?v=CBqOYAqS3p0">Listen to the audio here</a></p>
</header>
<!-- Place acc summary here -->
</body>
<body id="append_here">
<h1>Mad Money Recap</h1>
<h2>Segment 1: Market Recap and Pfizer's Earnings</h2>
<ul>
<li>Pfizer's CEO, Scott Boat, discussed the company's performance, revealing a 7.4% same-store sales growth driven by transaction growth of about 5.3%.</li>
<li>Boat emphasized the company's aggressive growth plans, aiming to open between 315 to 345 new restaurants across North America.</li>
<li>Pfizer has implemented an AI-powered hiring assistant, Ava Cado, which has reduced onboarding time by 75% and led to better quality hires.</li>
<li>Boat also addressed concerns about avocado sourcing, stating that only about 50% of their avocados come from Mexico, with the rest sourced from countries like Peru, Dominican Republic, and Colombia.</li>
<li>Pfizer's marketing strategy for the year includes limited-time offerings, such as the upcoming Chipotle honey chicken, which has performed well in tests.</li>
</ul>
<h2>Segment 2: Interview with Dr. Albert Bourla, Chairman and CEO of Pfizer</h2>
<ul>
<li>Dr. Bourla discussed Pfizer's performance, highlighting its ability to beat earnings and revenue expectations.</li>
<li>He attributed the success to the company's execution of its plan and its strong pipeline of products.</li>
<li>Dr. Bourla addressed concerns about Robert F. Kennedy Jr.'s potential impact on the vaccine industry, stating that he doesn't think Kennedy intends to remove liability protection for vaccines.</li>
<li>He discussed Pfizer's seven pivotal study starts and eight key phase three readouts, including a lung cancer treatment that has started phase three studies and a breast cancer treatment in first-line cancer.</li>
<li>Dr. Bourla also mentioned the company's COVID-19 vaccine, stating that it was developed during President Trump's term and has been a game-changer.</li>
</ul>
<h2>Segment 3: Interview with Ynon Kreiz, Chairman and CEO of Mattel</h2>
<ul>
<li>Kreiz discussed Mattel's strong quarterly performance, driven by growth in toy cars, action figures, and games.</li>
<li>He highlighted Uno's success, with its highest year on record, and the company's efforts to innovate and stay culturally relevant.</li>
<li>Kreiz addressed the impact of tariffs on Mattel's business, stating that the company has mitigated the effects through its diversified supply chain and pricing strategies.</li>
<li>He also discussed the company's plans for entertainment, including movies and a theme park, which is launching this year.</li>
<li>Kreiz mentioned the company's share buyback program, with $400 million in share repurchases in 2024 and another $600 million targeted for 2025.</li>
</ul>
<h2>Segment 4: Lightning Round</h2>
<ul>
<li>MongoDB (MDB): Cramer suggested it's worth a trade, but not an investment, due to its high valuation.</li>
<li>Tempest AI: Cramer recommended Striker or Metronic instead, citing their stronger growth prospects.</li>
<li>Coinbase (COIN): Cramer advised buying Bitcoin directly instead of the Coinbase stock, as the company's fees are too high.</li>
<li>AbbVie (ABBV): Cramer praised the company's dividend and growth prospects, driven by its strong pharmaceutical pipeline.</li>
<li>Palantir (PLTR): Cramer discussed the company's use of artificial intelligence to drive business efficiency and revenue growth.</li>
</ul>
<h2>Segment 5: Palantir's Earnings and Future Prospects</h2>
<ul>
<li>Palantir's CEO, Alex Karp, discussed the company's performance, highlighting its revenue growth rate and profit margin.</li>
<li>Karp emphasized Palantir's work with the Pentagon, aiming to reinvent the entire procurement process and make America more lethal.</li>
<li>Cramer praised Palantir's use of artificial intelligence and its potential for future growth, driven by its strong partnerships and innovative technology.</li>
<li>He noted that the stock is heavily shorted, and the shorts are now frantically buying back the stock to close out their positions, driving the stock price higher.</li>
<li>Cramer concluded that Palantir is a special company with a strong future ahead, and investors should consider buying the stock.</li>
</ul>
</body>
<body>
<!-- Signup Form -->
<form action="#" id="signup-form" method="post">
<input id="email" name="email" placeholder="Email Address" type="email"/>
<input type="submit" value="Sign Up"/>
</form>
<p> Reminder that AI-generated summary may be misleading or innaccurate due to malformed transcripts!</p> <br/><br/> <br/>
<!-- Footer -->
<footer id="footer">
<ul class="icons">
<li><a class="icon brands fa-twitter" href="#"><span class="label">Twitter</span></a></li>
<li><a class="icon brands fa-instagram" href="#"><span class="label">Instagram</span></a></li>
<li><a class="icon brands fa-github" href="#"><span class="label">GitHub</span></a></li>
<li><a class="icon fa-envelope" href="#"><span class="label">Email</span></a></li>
</ul>
<ul class="copyright">
<!-- <li>&copy; Untitled.</li> -->
<li>Credits for template: <a href="http://html5up.net">HTML5 UP</a></li>
</ul>
<!-- </footer> -->
<!-- Scripts -->
<script src="assets/js/main_test.js"></script>
</footer></body>
</html>